Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Rxo (RXO) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Rxo (RXO) over the last 4 years, with Q4 2025 value amounting to 0.04%.

  • Rxo's Return on Capital Employed fell 100.0% to 0.04% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.04%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.03% for FY2025, which is 0.0% changed from last year.
  • As of Q4 2025, Rxo's Return on Capital Employed stood at 0.04%, which was down 100.0% from 0.03% recorded in Q3 2025.
  • Rxo's 5-year Return on Capital Employed high stood at 0.09% for Q4 2022, and its period low was 0.04% during Q4 2025.
  • In the last 4 years, Rxo's Return on Capital Employed had a median value of 0.01% in 2024 and averaged 0.01%.
  • In the last 5 years, Rxo's Return on Capital Employed plummeted by -600bps in 2023 and then crashed by -100bps in 2025.
  • Rxo's Return on Capital Employed (Quarter) stood at 0.09% in 2022, then tumbled by -65bps to 0.03% in 2023, then tumbled by -174bps to 0.02% in 2024, then crashed by -50bps to 0.04% in 2025.
  • Its Return on Capital Employed stands at 0.04% for Q4 2025, versus 0.03% for Q3 2025 and 0.03% for Q2 2025.